knowledge -WSS

knowledge

author：knowledge 2025-08-03 10:41:56 - browse：732

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Radiation, mainstay of cancer treatment, begins a fade

knowledge

WSS

What AAP's gender

AstraZeneca challenges Medicare drug negotiation program

In science, is the line between industry and academia shifting?

NYU Langone launches private ChatGPT for its health care data

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

NYU Langone launches private ChatGPT for its health care data

Wikipedia

knowledge

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Sports medicine is finally prioritizing gender equality

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

United colonoscopy coverage change 'may cost lives,' doctors say

How Long Island became the ‘eugenics capital of the world’

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Researchers separate signal from noise in heart wearable data

Anesthesiologist group: stop taking Ozempic before surgery

Ebola public health emergency is over, WHO declares

focus

Radiation, mainstay of cancer treatment, begins a fade

Celebrate National Dole Whip Day for 3 days this week at Disney

In science, is the line between industry and academia shifting?

Apellis safety probe of eye disease drug centers on injection needle

Man who had jail sentence commuted by Trump arrested again

Couple fighting to bring baby home from Mexico are finally reunited

knowledge

focus

knowledge

focus